NeuroCure Visiting Fellows
The aim of NeuroCure's Visiting Fellows funding program is to integrate renowned foreign scientists into the Berlin research landscape to further strengthen the international profile of the universities and research facilities, and to foster collaborative projects.
Visiting Fellows are required to come to Berlin to participate actively in the research and teaching activities of the Cluster. This can take the form of, e.g., joint projects, the development of new technologies, or scientific lectures as a supplement to teaching.
Prof. Dr. Martyn Goulding has been a NeuroCure Visiting Fellow since April 2016. During his visits to Berlin, he works in the laboratory of Prof. Dr. Carmen Birchmeier at the MDC.
Martyn Goulding is Chair of the Molecular Neurobiology Laboratory at the Salk Institute for Biological Studies in La Jolla, Ca. Following PhD studies in molecular cell biology at the University of Auckland in New Zealand, he did postdoctoral work in developmental biology at the Max Planck Institute in Göttingen. He subsequently worked as MRC Senior Research Fellow at the University of London, UK, before moving to California for a professorship/adjunct professorship at the Salk Institute and University of California San Diego, Department of Biology, respectively.
Martyn Goulding’s research focuses on genetically identifying and functionally characterizing interneuron cell types in the spinal cord that make up the spinal sensorimotor circuitry. His lab has made fundamental discoveries regarding the identity and function of the spinal interneurons (INs) that generate and pattern rhythmic locomotor movements. Current research in his lab is directed at dissecting the spinal circuitry in the dorsal horn that transmits and gates pain, itch and innocuous touch.
Prof. Dr. Hans-Georg Kuhn has been a NeuroCure Visiting Fellow since April 2016. During his visits to Berlin, he works in the laboratory of Prof. Dr. Ulrich Dirnagl at the Charité, Department of Neurology.
Georg Kuhn is Professor for Regenerative Neuroscience at the Center for Brain Repair and Rehabilitation, University of Gothenburg, Sweden. Following doctoral studies in molecular neurobiology at the Heinrich Heine University Düsseldorf, he did postdoctoral work at the Department of Neurosciences, University of California San Diego, then the Laboratory of Genetics at the Salk Institute, California. He was subsequently Group Leader of the Neurogenesis lab at the University of Regensburg, and later lecturer at the Institute for Neuroscience and Physiology at the University of Gothenburg.
The goal of Kuhn’s research is to stimulate repair mechanisms in the brain to achieve structural and functional improvements following neurological disease. He focuses on characterizing mechanisms and signaling in the periphery that could stimulate cellular plasticity mechanisms in the CNS. This involves animal models for stroke and radiation damage, as well as cell culture models. Kuhn’s research is also associated with epidemiological investigations into the effect of cardiovascular fitness on cognition and neurological disease, and clinical studies on multi-sensory stimulation in late neurorehabilitation following stroke.
Prof. Dr. Cheng-Chang Lien has been a NeuroCure Visiting Fellow since April 2015. He works in the laboratory of Prof. Dr. Imre Vida at the Charité Institute of Integrative Neuroanatomy.
Cheng-Chang Lien is Associate Professor of Neuroscience at National Yang-Ming University in Taiwan. Following his medical studies at the China Medical University in Taiwan, he completed his PhD in physiology/neuroscience at the University of Freiburg. He subsequently worked as a postdoc at the University of Freiburg and thereafter the UC Berkeley before moving to National Yang-Ming University. In 2012 Cheng-Chang Lien was a visiting scientist in the Institute of Physiology and Pathophysiology at the University of Heidelberg.
Cheng-Chang Lien's laboratory applies a multidisciplinary approach including electrophysiology, pharmacology, molecular biology, optogenetics and computational modeling to uncover GABAergic neuron subtype-specific properties in the hippocampus, and their possible role in neurotransmission and abnormalities in learning and memory.
Prof. Dr. Alison Lloyd has been a NeuroCure Visiting Fellow since April 2015. She works in the laboratory of Prof. Dr. Britta Eickholt at the Charité Institute of Biochemistry.
Alison Lloyd is Senior Group Leader and Professor of Cell Biology at the MRC Laboratory for Molecular Cell Biology and UCL Cancer Institute, University College London. Following PhD studies in cell and molecular biology at the Institute for Cancer Research, Chester Beatty Laboratories, London, she worked as a postdoctoral fellow at the Faculté de Médecine in Strasbourg, and thereafter as Manager of Technology Transfer at the Ludwig Institute for Cancer Research, London. Prior to her current position, she was a postdoctoral fellow at the Imperial Cancer Research Fund Laboratories in London.
Alison Lloyd's research focuses on cell biogenesis and tissue regeneration and the role of these processes in cancer, using the mammalian peripheral nervous system (PNS) as a model system. Her work is not only relevant for cancer biology, but also for the tumour predisposition syndrome, Neurofibromatosis Type 1 (NF1).
Dr. Panayiota Poirazi has been a NeuroCure Visiting Fellow since April 2016. During her visits to Berlin, she works in the laboratory of Prof. Dr. Matthew Larkum at the Humboldt-Universität zu Berlin, Department of Biology.
Panayiota Poirazi is currently a Research Director (equivalent to full professor) at the Institute of Molecular Biology & Biotechnology, Foundation for Research & Technology-Hellas (IMBB-FORTH), a Center of Excellence in Greece. Following doctoral studies in biomedical engineering at the University of Southern California, Los Angeles, she did postdoctoral work in bioinformatics at the Biomedical Sciences Research Center “Alexander Fleming”, Institute of Immunology in Greece. Thereafter, she joined IMBB-FORTH as a Marie Curie Postdoctoral Researcher.
Panayiota Poirazi is an internationally recognized computational neuroscientist with extensive expertise on developing computational models of neural cells and circuits that are used to understand information processing and learning and memory mechanisms. Her research places special emphasis on understanding how dendrites contribute to information processing and memory capacity of the neural tissue. Her modelling work has resulted in a number of experimentally testable predictions that have greatly influenced the neuroscience field, leading to high-profile experimental studies that have verified these predictions.
Prof. Dr. Evgeny Rogaev has been a NeuroCure Visiting Fellow since April 2016. During his visits to Berlin, he works in the laboratory of Prof. Dr. Victor Tarabykin at the Charité, Institute of Cell Biology and Neurobiology.
Evgeny Rogaev is Professor of Psychiatry at the University of Massachusetts. Following PhD studies in medical genetics at the Russian Academy of Medical Sciences (RAMS) in Moscow, he worked as head of the Molecular Brain Genetics lab at the National Research Center of Mental Health, RAMS. During this time, he also worked as a Visiting Scientist and Visiting Professor at the Centre for Research in Neurodegenerative Diseases at University of Toronto before moving to the USA for his current position. He has also held the position of head of the Evolutionary Genomics lab at the Vavilov Institute of General Genetics in Moscow.
Evgeny Rogaev has experience in both experimental research and bioinformatics. He is known for his landmark discovery of presenilins, the major genes for Alzheimer’s disease. His laboratory has also established high-throughput genomic technologies, which he applies in different neuroscience fields. His current research focuses on elucidating genetic-epigenetic interactions as a putative mechanism underlying many complex neuropsychiatric disorders, including schizophrenia, affective disorders and dementias.
Prof. Dr. Hermona Soreq has been a NeuroCure Visiting Fellow since April 2015. She works in the laboratory of Prof. Dr. Andreas Meisel at the Charité Institute for Neurology.
Hermona Soreq studied molecular biology at the Weizmann Institute of Science and joined the Hebrew University in 1986. She holds the Slesinger Chair of Molecular Neuroscience and is a founding member of the Hebrew University's Edmond and Lily Safra Center for Brain Science.
Hermona Soreq's research is centered on acetylcholine functioning. She pioneered the application of molecular biology and genomics to the study of cholinergic signaling, with a recent focus on its microRNA regulation, and is interested in the checks and brain-to-body blaances of cholinergic mechanisms in health and disease.
Prof. Dr. Roger Traub has been a NeuroCure Visitng Fellow since December 2014. He works in the laboratory of Prof. Dr. Dietmar Schmitz at the Neuroscience Research Center (NWFZ) at the Charité and Prof. Dr. Michael Brecht at the Bernstein Center for Computational Neuroscience Berlin (BCCN) at the Humboldt-Universität zu Berlin.
Roger Traub studied mathematics at Princeton University and completed his medical studies at the University of Pennsylvania. Since 2001, he has been Professor for Physiology, Pharmacology and Neurology at the State University of New York. In addition, he works as a research member for IBM at the Watson Research Center.
Roger Traub is an expert in the computer simulation of circuits between cortical neurons, which are used, for example, in epilepsy research. In cooperation with the working groups of Dietmar Schmitz and Michael Brecht, Roger Traub researches rapid network oscillations and intracellular spikes and spikelets both in vitro and in vivo. Due to Traub's realistic simulations, characteristic, verifiable predictions can now be made. This enables NeuroCure scientists to carry out deeper analyses on even cryptic experimental observations.
Former NeuroCure Visiting Fellows
The following researchers have enriched the Berlin neuroscience landscape as NeuroCure Visiting Fellows:
Alison L. Barth, Carnegie Mellon University, USA
Burkhard Becher, University of Zurich, Switzerland
Craig C. Garner, Stanford University School of Medicine, USA
Matthew Holt, Katholieke Universiteit Leuven, Belgium
Erik Jorgensen, University of Utah, USA
Brian MacVicar, University of British Columbia, Canada
Istvan Mody, University of California UCLA School of Medicine, USA
Israel Sekler, Ben-Gurion University, Israel
Tony Wyss-Coray, Stanford University School of Medicine, USA